FDA Panel Supports Pfizer Vaccine for Children

This chapter covers the FDA advisory panel's unanimous approval of the Pfizer vaccine for children aged 5 to 11. It outlines the proposed dosage and hints at the upcoming guidance from the CDC.

Play episode from 05:24

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app